Concepedia

Badarch Uranchimeg

BU

Statistics

Publications

16

Citations

2.6K

H-Index

15

Active since

2002

Affiliations

Science Applications International Corporation (United States)(Current)

National Cancer Institute

Center for Cancer Research

Frederick National Laboratory for Cancer Research

Badarch Uranchimeg is an author at Science Applications International Corporation (United States) specializing in hif-1 alpha regulation, signal transduction, and medicine.

Publications per year

2002–2010

16

Publications

16

Regulation of the Chemokine Receptor CXCR4 by Hypoxia

Tiziana Schioppa, Badarch Uranchimeg, Alessandra Saccani et al. · The Journal of Experimental Medicine · 2003 · 833 citations · Full text

, , +17

Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Annamaria Rapisarda, Badarch Uranchimeg, Dominic A. Scudiero et al. · PubMed · 2002 · 458 citations

, , +16

Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1

Annamaria Rapisarda, Badarch Uranchimeg, Olivier Sordet et al. · Cancer Research · 2004 · 299 citations

, , +14

Hypoxic induction of an HIF-1α–dependent bFGF autocrine loop drives angiogenesis in human endothelial cells

Maura Calvani, Annamaria Rapisarda, Badarch Uranchimeg et al. · Blood · 2005 · 228 citations · Full text

, , +13

Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts

Annamaria Rapisarda, J. Zalek, Melinda G. Hollingshead et al. · Cancer Research · 2004 · 187 citations

, , +16

1–5 of 16